[go: up one dir, main page]

AR028411A1 - Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos - Google Patents

Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos

Info

Publication number
AR028411A1
AR028411A1 ARP010102128A ARP010102128A AR028411A1 AR 028411 A1 AR028411 A1 AR 028411A1 AR P010102128 A ARP010102128 A AR P010102128A AR P010102128 A ARP010102128 A AR P010102128A AR 028411 A1 AR028411 A1 AR 028411A1
Authority
AR
Argentina
Prior art keywords
nuclentids
mameferos
endice
ovulation
sequences
Prior art date
Application number
ARP010102128A
Other languages
English (en)
Original Assignee
Agres Ltd
Olli Visa Pekka Ritvos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd, Olli Visa Pekka Ritvos filed Critical Agres Ltd
Publication of AR028411A1 publication Critical patent/AR028411A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010102128A 2000-05-05 2001-05-04 Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos AR028411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ500844A NZ500844A (en) 2000-05-05 2000-05-05 Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate

Publications (1)

Publication Number Publication Date
AR028411A1 true AR028411A1 (es) 2003-05-07

Family

ID=19927611

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102128A AR028411A1 (es) 2000-05-05 2001-05-04 Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos

Country Status (15)

Country Link
US (1) US20040092007A1 (es)
EP (1) EP1292674B1 (es)
JP (1) JP2003532414A (es)
CN (1) CN1436237A (es)
AR (1) AR028411A1 (es)
AT (1) ATE401403T1 (es)
AU (2) AU2001260821B2 (es)
BR (1) BR0110616A (es)
CA (1) CA2408051A1 (es)
DE (1) DE60134852D1 (es)
MX (1) MXPA02010868A (es)
NZ (1) NZ500844A (es)
RU (1) RU2283866C2 (es)
WO (1) WO2001085926A2 (es)
ZA (1) ZA200208963B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
RU2007124578A (ru) * 2004-12-02 2009-01-10 Агрисерч Лимитед (Nz) Модуляция овуляции
EP1947195B1 (en) * 2005-09-13 2010-11-10 Neocodex, S.L. Method for the in vitro detection of a predisposition to the development of alterations in ovarian function
ES2338960B1 (es) * 2007-11-23 2011-04-19 Carnes Oviaragon S.C.L. Procedimiento de mejora de la productividad en ganado ovino.
CN105210981B (zh) * 2015-09-15 2018-09-28 中国科学院生物物理研究所 建立可应用于人类疾病研究的雪貂模型的方法及其应用
CN105941325A (zh) * 2016-06-17 2016-09-21 安徽省农业科学院畜牧兽医研究所 小尾寒羊母羊与澳洲白公羊杂交生产澳寒杂交母羊的方法
CN106614366A (zh) * 2016-12-29 2017-05-10 李振民 一种无抗生猪养殖方法
CN108753835A (zh) * 2018-05-30 2018-11-06 中山大学 一种利用CRISPR/Cas9编辑猪BMP15基因的方法
CN111500744A (zh) * 2020-04-27 2020-08-07 内蒙古大学 一种基于gdf9基因编码区突变的蒙古羊繁殖力提高方法
CN111440879A (zh) * 2020-04-27 2020-07-24 内蒙古大学 一种利用gdf9基因提高蒙古羊繁殖力的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions

Also Published As

Publication number Publication date
CN1436237A (zh) 2003-08-13
JP2003532414A (ja) 2003-11-05
ATE401403T1 (de) 2008-08-15
WO2001085926A3 (en) 2002-08-08
MXPA02010868A (es) 2004-09-06
DE60134852D1 (de) 2008-08-28
BR0110616A (pt) 2004-04-06
US20040092007A1 (en) 2004-05-13
CA2408051A1 (en) 2001-11-15
EP1292674A2 (en) 2003-03-19
AU2001260821B2 (en) 2006-04-13
ZA200208963B (en) 2004-07-26
EP1292674B1 (en) 2008-07-16
AU6082101A (en) 2001-11-20
NZ500844A (en) 2003-06-30
WO2001085926A2 (en) 2001-11-15
RU2283866C2 (ru) 2006-09-20

Similar Documents

Publication Publication Date Title
FI20000416L (fi) Ihmiselimistöön liittyvä mittaus
DE60037275D1 (de) Geschlechtsbestimmung
NO2012018I1 (no) Canakinumab eller direkte ekvivalenter derav
DE60121228D1 (de) Beschädigungen des benachbarten gewebes reduzierendes, elektrochirurgisches instrument
ITRM20000483A0 (it) Capo di abbigliamento strutturato per la protezione del motociclista.
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
DK1294644T3 (da) Vandbehandlingssammensætninger
EP1608964A4 (en) CREATING AN EXPRESSION PROFILE OF TUMORS
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
ATE272998T1 (de) Hautreinigungszusammensetzung mit verbesserter stabilität
DE69811330D1 (de) Reinigungspflaster zur verbesserung des hautzustandes
DE60223576D1 (de) Hautbehandlungszusammensetzung
AR028411A1 (es) Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos
FI20001733A0 (fi) Refraktometri
EP1409454A4 (en) INCREASED BIOVERABILITY OF CAROTENOIDS
ATE387204T1 (de) Zusammensetzung mit induzierendem kathartischen effekt
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
IT251494Y1 (it) Bracciale tecnico ad alta visibilita' del tipo con tasca
ID29706A (id) Artikel kesehatan sekali pakai
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo
MD2053B1 (en) Remedy with interferon inducing action
NO20030762D0 (no) Forbedret spesifisitet i behandling av sykdommer
AR025773A4 (es) Disposicion para separar el palito, fibra, pelusas del te
FI20002081L (fi) Korin tukirakenne

Legal Events

Date Code Title Description
FB Suspension of granting procedure